Literature DB >> 17213474

Hepatic autoregulation: response of glucose production and gluconeogenesis to increased glycogenolysis.

Peter Staehr1, Ole Hother-Nielsen, Henning Beck-Nielsen, Michael Roden, Harald Stingl, Jens J Holst, Paul K Jones, Visvanathan Chandramouli, Bernard R Landau.   

Abstract

The effect of increased glycogenolysis, simulated by galactose's conversion to glucose, on the contribution of gluconeogenesis (GNG) to hepatic glucose production (GP) was determined. The conversion of galactose to glucose is by the same pathway as glycogen's conversion to glucose, i.e., glucose 1-phosphate --> glucose 6-phosphate --> glucose. Healthy men (n = 7) were fasted for 44 h. At 40 h, hepatic glycogen stores were depleted. GNG then contributed approximately 90% to a GP of approximately 8 micromol.kg(-1).min(-1). Galactose, 9 g/h, was infused over the next 4 h. The contribution of GNG to GP declined from approximately 90% to 65%, i.e., by approximately 2 micromol.kg(-1).min(-1). The rate of galactose conversion to blood glucose, measured by labeling the infused galactose with [1-(2)H]galactose (n = 4), was also approximately 2 micromol.kg(-1).min(-1). The 41st h GP rose by approximately 1.5 micromol.kg(-1).min(-1) and then returned to approximately 9 micromol.kg(-1).min(-1), while plasma glucose concentration increased from approximately 4.5 to 5.3 mM, accompanied by a rise in plasma insulin concentration. Over 50% of the galactose infused was accounted for in blood glucose and hepatic glycogen formation. Thus an increase in the rate of GP via the glycogenolytic pathway resulted in a concomitant decrease in the rate of GP via GNG. While the compensatory response to the galactose administration was not complete, since GP increased, hepatic autoregulation is operative in healthy humans during prolonged fasting.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17213474     DOI: 10.1152/ajpendo.00411.2006

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  6 in total

1.  Endogenous glucose production increases in response to metformin treatment in the glycogen-depleted state in humans: a randomised trial.

Authors:  Mette Marie H Christensen; Kurt Højlund; Ole Hother-Nielsen; Tore B Stage; Per Damkier; Henning Beck-Nielsen; Kim Brøsen
Journal:  Diabetologia       Date:  2015-08-14       Impact factor: 10.122

2.  Hepatic glucose production and insulin resistance.

Authors:  Michael Roden
Journal:  Wien Med Wochenschr       Date:  2008

3.  Impact of a glycogen phosphorylase inhibitor and metformin on basal and glucagon-stimulated hepatic glucose flux in conscious dogs.

Authors:  Tracy P Torres; Noriyasu Sasaki; E Patrick Donahue; Brooks Lacy; Richard L Printz; Alan D Cherrington; Judith L Treadway; Masakazu Shiota
Journal:  J Pharmacol Exp Ther       Date:  2011-03-01       Impact factor: 4.030

4.  Gluconeogenesis and hepatic glycogenolysis during exercise at the lactate threshold.

Authors:  Chi-An W Emhoff; Laurent A Messonnier; Michael A Horning; Jill A Fattor; Thomas J Carlson; George A Brooks
Journal:  J Appl Physiol (1985)       Date:  2012-12-13

5.  High protein diet maintains glucose production during exercise-induced energy deficit: a controlled trial.

Authors:  Tracey J Smith; Jean-Marc Schwarz; Scott J Montain; Jennifer Rood; Matthew A Pikosky; Carmen Castaneda-Sceppa; Ellen Glickman; Andrew J Young
Journal:  Nutr Metab (Lond)       Date:  2011-04-28       Impact factor: 4.169

6.  Quantifying the contribution of the liver to glucose homeostasis: a detailed kinetic model of human hepatic glucose metabolism.

Authors:  Matthias König; Sascha Bulik; Hermann-Georg Holzhütter
Journal:  PLoS Comput Biol       Date:  2012-06-21       Impact factor: 4.475

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.